To determine if indomethacin has a positive clinical effect for the prophylaxis of heterotopic ossification (HO) after acetabular fracture surgery. To determine whether indomethacin affects the union rate of acetabular fractures.
Design: Prospective randomized double-blinded trial.
Setting: Level 1 regional trauma center.
Patients: Skeletally mature patients treated operatively for an acute acetabular fracture through a Kocher-Langenbeck approach.
Intervention: Patients were randomly allocated to 1 of 4 groups comparing placebo (group 1) to 3 days (group 2), 1 week (group 3), and 6 weeks (group 4) of indomethacin treatment.
Main Outcome Measures:
Treatment with 6 weeks of indomethacin does not appear to have a therapeutic effect for decreasing HO formation after acetabular fracture surgery and appears to increase the incidence of nonunion. Treatment with 1 week of indomethacin may be beneficial for decreasing the volume of HO formation without increasing the incidence of nonunion.
Level of evidence: Therapeutic Level II. Copyright remains with the authors and publisher.
To determine if indomethacin has a positive clinical effect for the prophylaxis of heterotopic ossification (HO) after acetabular fracture surgery. To determine whether indomethacin affects the union rate of acetabular fractures.
Design: Prospective randomized double-blinded trial.
Setting: Level 1 regional trauma center.
Patients: Skeletally mature patients treated operatively for an acute acetabular fracture through a Kocher-Langenbeck approach.
Intervention: Patients were randomly allocated to 1 of 4 groups comparing placebo (group 1) to 3 days (group 2), 1 week (group 3), and 6 weeks (group 4) of indomethacin treatment.
Main Outcome Measures:
Treatment with 6 weeks of indomethacin does not appear to have a therapeutic effect for decreasing HO formation after acetabular fracture surgery and appears to increase the incidence of nonunion. Treatment with 1 week of indomethacin may be beneficial for decreasing the volume of HO formation without increasing the incidence of nonunion.
Level of evidence: Therapeutic Level II. Copyright remains with the authors and publisher.